The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer
Zhu, S., Gilbert, C.J.(2020) J Thromb Haemost 18: 1113-1123
- PubMed: 32011054 
- DOI: https://doi.org/10.1111/jth.14755
- Primary Citation of Related Structures:  
7F49 - PubMed Abstract: 
Thrombus formation involves coagulation proteins and platelets. The latter, referred to as platelet-mediated thrombogenesis, is predominant in arterial circulation. Platelet thrombogenesis follows vascular injury when extracellular von Willebrand factor (VWF) binds via its A3 domain to exposed collagen, and the free VWF A1 domain binds to platelet glycoprotein Ib (GPIb).
Organizational Affiliation: 
Guardian Therapeutics Inc, Lexington, Massachusetts, USA.